These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31383555)

  • 41. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The medical abortion experiences of married and unmarried women in Tunis, Tunisia.
    Blum J; Hajri S; Chélli H; Mansour FB; Gueddana N; Winikoff B
    Contraception; 2004 Jan; 69(1):63-9. PubMed ID: 14720623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Demand for Self-Managed Medication Abortion Through an Online Telemedicine Service in the United States.
    Aiken ARA; Starling JE; van der Wal A; van der Vliet S; Broussard K; Johnson DM; Padron E; Gomperts R; Scott JG
    Am J Public Health; 2020 Jan; 110(1):90-97. PubMed ID: 31622157
    [No Abstract]   [Full Text] [Related]  

  • 44. Implementing medical abortion with mifepristone and misoprostol in Norway 1998-2013.
    Løkeland M; Bjørge T; Iversen OE; Akerkar R; Bjørge L
    Int J Epidemiol; 2017 Apr; 46(2):643-651. PubMed ID: 28031316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flexible mifepristone and misoprostol administration interval for first-trimester medical termination.
    Wedisinghe L; Elsandabesee D
    Contraception; 2010 Apr; 81(4):269-74. PubMed ID: 20227541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early medical abortion: a new regimen up to 49 days' gestation.
    Ashima T; Vinita A; Shalini R
    Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):137-9. PubMed ID: 15760315
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Timing and indication for curettage after medical abortion in early pregnant women with prior uterine incision.
    Wang G; Li D; Manconi F; Dong B; Zhang Y; Sun B
    Contraception; 2010 Jan; 81(1):62-6. PubMed ID: 20004275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine: results of two clinical trials.
    Raghavan S; Maistruk G; Shochet T; Bannikov V; Posohova S; Zhuk S; Lishchuk V; Winikoff B
    Eur J Contracept Reprod Health Care; 2013 Apr; 18(2):112-9. PubMed ID: 23465062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Home use of two doses of misoprostol after mifepristone for medical abortion: a pilot study in Sweden and France.
    Clark WH; Hassoun D; Gemzell-Danielsson K; Fiala C; Winikoff B
    Eur J Contracept Reprod Health Care; 2005 Sep; 10(3):184-91. PubMed ID: 16318966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The mifepristone-misoprostol regimen for early medical abortion.
    Ellertson C; Waldman SN
    Curr Womens Health Rep; 2001 Dec; 1(3):184-90. PubMed ID: 12112968
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mifepristone-misoprostol medical abortion: home administration of misoprostol in Guadeloupe.
    Guengant JP; Bangou J; Elul B; Ellertson C
    Contraception; 1999 Sep; 60(3):167-72. PubMed ID: 10640161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion.
    Winikoff B; Sivin I; Coyaji KJ; Cabezas E; Xiao B; Gu S; Du MK; Krishna UR; Eschen A; Ellertson C
    Am J Obstet Gynecol; 1997 Feb; 176(2):431-7. PubMed ID: 9065194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can women in less-developed countries use a simplified medical abortion regimen?
    Elul B; Hajri S; Ngoc NN; Ellertson C; Slama CB; Pearlman E; Winikoff B
    Lancet; 2001 May; 357(9266):1402-5. PubMed ID: 11356438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Medical methods of early abortion in developing countries. Consensus statement. The Population Council.
    Contraception; 1998 Nov; 58(5):257-9. PubMed ID: 9883380
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial.
    Grimes DA; Smith MS; Witham AD
    BJOG; 2004 Feb; 111(2):148-53. PubMed ID: 14723752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion among women in Mexico City.
    Peña M; Dzuba IG; Smith PS; Mendoza LJ; Bousiéguez M; Martínez ML; Polanco RR; Villalón AE; Winikoff B
    Int J Gynaecol Obstet; 2014 Oct; 127(1):82-5. PubMed ID: 24957534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reaching women where they are: eliminating the initial in-person medical abortion visit.
    Raymond EG; Grossman D; Wiebe E; Winikoff B
    Contraception; 2015 Sep; 92(3):190-3. PubMed ID: 26134280
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion.
    Kapp N; Borgatta L; Ellis SC; Stubblefield P
    Contraception; 2006 May; 73(5):525-7. PubMed ID: 16627039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current medical abortion care.
    Creinin MD
    Curr Womens Health Rep; 2003 Dec; 3(6):461-9. PubMed ID: 14613667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.